Outcome of patients undergoing radical cystectomy for invasive bladder cancer.
Gschwend
Jürgen E
JE
Department of Urology, University of Ulm, Germany. juergen.gschwend@medizin.uni-ulm.de
D000206:Actuarial Analysis; D001500:BCG Vaccine / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000401:mortality / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D003131:Combined Modality Therapy; D015653:Cystectomy; D018572:Disease-Free Survival; D005188:False Negative Reactions; D005189:False Positive Reactions; D006801:Humans; D007167:Immunotherapy; D008197:Lymph Node Excision; D008279:Magnetic Resonance Imaging; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D016019:Survival Analysis; D015996:Survival Rate; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery* / Q000628:therapy
D001500:BCG Vaccine